Mark Whitaker - Concepedia

Author

Mark Whitaker

Also Known As

M O Whitaker, Mark O. Whitaker, Mark Whitaker

Publications

306

Citations

H-Index

Concepts

All Affiliations

Mark Whitaker is an author at Washington University in St. Louis specializing in medicine, pharmacology, and thrombosis.

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	155
2	Pharmacology	2	2	155
3	Biochemistry	1	1	130
4	Drug Discovery	1	1	25
5	Physiology	1	1	25

Mark Whitaker

Publications

300

Citations

H-Index

Page 1

	Year	Citations
Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: Pharmacological basis for a therapeutic approach Philip Needleman, Mark Whitaker, Angela Wyche, Prostaglandins ThrombopoiesisThrombosisBiochemistryBlood PlateletMedicine	1980	130
Triene prostaglandins: Prostaglandin D <sub>3</sub> and icosapentaenoic acid as potential antithrombotic substances Mark Whitaker, Angela Wyche, F.A. Fitzpatrick, Proceedings of the National Academy of Sciences	1979	123
A new class of 5-HT2B antagonists possesses favorable potency, selectivity, and rat pharmacokinetic properties Neil Moss, Younggi Choi, Derek A. Cogan, Bioorganic & Medicinal Chemistry Letters Functional SelectivityMedicineFavorable PotencyPhysiologyPharmacological Agent	2009	25
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 Debra Tompson, Mark Whitaker, Rennan Pan, Pharmaceutical Research	2021	11
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology Debra Tompson, Mark Whitaker, Rennan Pan, Pharmaceutical Research	2022	11

Page 1